CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 13 enrolled
Drug / intervention
infliximab +1 moredrug
Likely dose
infliximab 5mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00589628
NCT00589628Phase 4Completed
CompareCT.gov

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

Egla C. Rabinovich·interventional·Posted Jan 10, 2008·Updated Aug 26, 2013

In Brief

A Phase 4 clinical trial evaluating infliximab for Chronic Uveitis. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The primary objective of this study is to examine the efficacy of infliximab for the treatment of persistent uveitis in children. Participants (4-18 years of age) will be randomly assigned to either 5mg/kg or 10mg/kg dose of infliximab to be administered by intravenous infusion at four week intervals. Participant responses will be measured at at four to eight week intervals for up to ten months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Uveitis
CountriesUnited States
CollaboratorsChildhood Arthritis and Rheumatology Research Alliance

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 10, 2008
Enrollment StartSep 1, 2007
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 18.5 years ago

Interventions

infliximabdrug

5mg/kg/dose IV at 4 week intervals

infliximabdrug

10mg/kg/dose IV at 4 week intervals